Related Experiment Video
Updated: Jul 21, 2026

Mechanical Stimulation of Chondrocyte-agarose Hydrogels
Published on: October 28, 2012
Cartilage tissue engineering using human auricular chondrocytes embedded in different hydrogel materials
Hisayo Yamaoka1, Hirotaka Asato, Toru Ogasawara
1Department of Fujisoft ABC Cartilage and Bone Regeneration, Graduate School of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-Ku, Tokyo 113-0033, Japan.
This study compared three different hydrogels—animal-derived atelopeptide collagen, plant-based alginate, and synthetic PuraMatrix—for their ability to support cartilage tissue engineering. Human ear chondrocytes were embedded in each material to assess cell growth, matrix production, and mechanical properties. Atelopeptide collagen supported the best cell proliferation and matrix synthesis, while PuraMatrix had weaker gelling properties despite offering lower disease transmission risks. The results suggest that atelopeptide collagen is a strong candidate for clinical use, but synthetic hydrogels may benefit from improvements in gelling ability to better support cartilage regeneration.
Area of Science:
- Tissue engineering in regenerative medicine
- Cartilage biology within orthopedic research
- Biomaterials development for clinical applications
Background:
Cartilage tissue engineering requires scaffolds that support cell survival and matrix production. Current materials include natural and synthetic hydrogels, but their performance varies. Prior research has shown that hydrogels influence chondrocyte behavior through mechanical and biochemical signals. However, the clinical suitability of these materials remains uncertain. No prior work had resolved how clinical availability interacts with biological performance in hydrogels. This gap motivated a comparison of clinically accessible hydrogels using human auricular chondrocytes. The study aimed to identify a scaffold that supports both cell proliferation and matrix synthesis. Biological effects and clinical readiness were prioritized in the evaluation. The knowledge base lacked a direct comparison of these hydrogels in cartilage regeneration.
Purpose Of The Study:
The goal was to evaluate the suitability of different hydrogels for cartilage tissue engineering. Human auricular chondrocytes were selected as a cell source due to their availability and similarity to articular cartilage. The hydrogels tested included atelopeptide collagen, alginate, and PuraMatrix. Each material was chosen based on its clinical availability or potential for future use. The study aimed to determine which hydrogel best supports cell proliferation and matrix synthesis. The researchers also sought to understand how each material influences gene expression and mechanical properties. A high-cell density culture was used to simulate in vivo conditions. The ultimate aim was to identify a scaffold that balances biological performance and clinical accessibility.
Main Methods:
The study involved embedding human auricular chondrocytes in three hydrogels: atelopeptide collagen, alginate, and PuraMatrix. Cell proliferation was assessed using standard viability assays. Gene expression of collagen type II and N-cadherin was measured via qPCR. Matrix accumulation was evaluated using biochemical assays for glycosaminoglycans and collagen. Mechanical properties were analyzed using Young’s modulus measurements. The hydrogels were either used alone or in combination with growth factor stimulation. Cultures were maintained in high-cell density to mimic in vivo environments. The results were compared across all three materials to determine performance differences.
Main Results:
Chondrocytes in atelopeptide collagen showed the highest proliferation rate compared to the other hydrogels. Collagen type II mRNA expression increased significantly in all hydrogels when cultured at high cell density. Stimulation with insulin and BMP-2 led to increased accumulation of collagen type II and glycosaminoglycans in all groups. Beta1 integrin expression was elevated in atelopeptide collagen, suggesting enhanced cell-matrix signaling. N-cadherin expression was reduced in alginate, possibly due to decreased cell-cell interactions. PuraMatrix had lower matrix synthesis and the lowest Young’s modulus, indicating weaker gelling properties. All hydrogels supported some level of matrix production, but atelopeptide collagen outperformed the others. These findings suggest that material composition directly influences biological outcomes.
Conclusions:
Atelopeptide collagen showed superior biological performance in supporting chondrocyte proliferation and matrix synthesis. Its clinical availability makes it a promising candidate for cartilage tissue engineering. However, synthetic peptides like PuraMatrix offer advantages in reducing disease transmission risks and immunological responses. The gelling ability of PuraMatrix was found to be a limiting factor in its effectiveness. The study highlights the importance of balancing biological performance with clinical readiness. The researchers propose that improvements in synthetic hydrogels could enhance their utility for cartilage regeneration. The findings suggest that material choice significantly affects tissue formation outcomes. These results may guide future scaffold development for clinical applications.
Frequently Asked Questions
Atelopeptide collagen supported the highest chondrocyte proliferation and matrix synthesis compared to alginate and PuraMatrix.
High-cell density culture significantly increased collagen type II mRNA expression in all tested hydrogels.
N-cadherin expression was inhibited in alginate, suggesting decreased cell-to-cell contacts may preserve chondrocyte activity.
Elevated beta1 integrin expression in atelopeptide collagen suggests enhanced cell-matrix signaling.
PuraMatrix had the lowest Young’s modulus, indicating weaker gelling ability and matrix storage.
Synthetic hydrogels reduce disease transmission risks and immunological responses compared to natural materials.

